Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| A1M Pharma | 141,486 | net | 30 Nov 2021 | tx 2+141,486 |
| Simris Group AB | 37,000 | net | 05 Nov 2019 | tx 3+37,000 |
| Qlucore AB | 30,060 | net | 05 Nov 2021 | tx 2+30,060 |
| Klövern AB | -11,500 | net | 15 Jun 2021 | tx 3+27,875−39,375 |
| Scandi Standard AB (publ) | 2,740 | net | 12 May 2026 | tx 2+2,740 |
| Devyser Diagnostics AB | 2,450 | net | 23 Feb 2024 | tx 2+2,450 |
5 purchases reported after at least 12 months of silence — most recent on 12 May 2026.
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 12 May 2026 | PURCHASE | Scandi Standard AB (publ) | 1,400 | 142.38 SEK | first after silence |
| 22 May 2024 | PURCHASE | Scandi Standard AB (publ) | 1,340 | 75.00 SEK | |
| 23 Feb 2024 | PURCHASE | Devyser Diagnostics AB | 950 | 91.00 SEK | first after silence |
| 10 Dec 2021 | PURCHASE | Devyser Diagnostics AB | 1,500 | 90.00 SEK | |
| 30 Nov 2021 | GRANT_AWARD | A1M Pharma | 60,000 | 0.00 SEK | deriv |
| 09 Nov 2021 | PURCHASE | A1M Pharma | 81,486 | 1.36 SEK | |
| 05 Nov 2021 | PURCHASE | Qlucore AB | 25,410 | 64.50 SEK | anomaly |
| 01 Nov 2021 | PURCHASE | Qlucore AB | 4,650 | 64.50 SEK | |
| 15 Jun 2021 | SALE | Klövern AB | 39,375 | 18.54 SEK | |
| 04 Dec 2020 | PURCHASE | Klövern AB | 7,875 | 10.00 SEK | first after silence |
| 05 Nov 2019 | PURCHASE | Simris Group AB | 2,000 | 14.00 SEK | first after silence |
| 10 Sept 2018 | PURCHASE | Simris Group AB | 10,000 | 6.50 SEK | first after silence |
| 10 Sept 2018 | PURCHASE | Simris Group AB | 25,000 | 0.00 SEK | |
| 28 Apr 2017 | PURCHASE | Klövern AB | 20,000 | 9.30 SEK |